CLOs on the Move

IntelGenx

www.intelgenx.com

 
IntelGenx is a leading drug delivery company focused on the development and manufacturing of pharmaceutical films. IntelGenx`s superior film technologies, including VersaFilm®, VetaFilm™ and transdermal, allow for next generation pharmaceutical products that address unmet medical needs. IntelGenx`s innovative product pipeline offer significant benefits to patients and physicians for many therapeutic conditions. IntelGenx`s highly skilled team provides comprehensive pharmaceuticals services to pharmaceutical partners, including R&D, analytical method development, clinical monitoring, IP and regulatory services. IntelGenx`s state-of-the-art manufacturing facility offers full service by providing lab-scale through to pilot- and commercial-scale production.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.intelgenx.com
  • 6420 Rue Abrams
    Saint-Laurent, QC CAN H4S 1Y2
  • Phone: 514.331.7440

Executives

Name Title Contact Details
Tommy Kenny
Vice President of Intellectual Property and Legal Affairs and General Counsel Profile

Similar Companies

Kirby Cleaning

Do you work long hours or Just not enough hours in the day? Relief is just a phone call away. Get your life back, let me clean your home!

Paramount Pharmacies Limited

Paramount Pharmacies Limited is a New Waterford, NS-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Osco Drug

Osco Drug is a Springfield, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Vista Pharmaceuticals

Vista Pharmaceuticals is a West Orange, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Accumulus

Accumulus Synergy is a global, non-profit organization that is developing a transformative data exchange platform that aims to enable enhanced collaboration and efficiency between life sciences organizations and global health authorities, while also affording users the ability to extract dynamic, data-driven insights from knowledge management. Sponsored by leading biopharmaceutical companies, Accumulus Synergy was formed in 2020 to create innovative solutions that can reduce regulatory review times and transform global data exchange. The non-profit company is creating a first-of-its-kind cloud-based platform between the biopharmaceutical industry and health authorities worldwide. The single-platform approach aims to improve speed, transparencies and efficiencies in the regulatory process by leveraging advanced technology and tools for data exchange. This will help reduce the cost of innovation and ultimately bring patients safe and effective medicines faster.